Index Therapeutics Private Limited

Index Therapeutics Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2005PTC045669 Incorporated 18 March 2005 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹1.13 Cr
▲ 11% YoY
Net profit · FY 2024
₹2.09 Lakh
Net margin 1.9%
EBITDA · FY 2024
₹12.73 Lakh
EBITDA margin 11.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹77.35 Lakh
Secured borrowings
Company age
21 yrs
Est. 2005
Directors on board
2
As per MCA filings

About Index Therapeutics Private Limited

Data last updated:

Index Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 March 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2005PTC045669. Its GSTIN is 36AABCI3485K1ZA (Telangana).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Francis Johnson Puthukkara (Managing Director) and Joicy Johnson.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 – 11 – 102/52 Behind Hanuman Temple Bhavani Nagar Mallapur, Hyderabad, Telangana, India – 500076.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.13 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹2.09 Lakh (net margin 1.9%) and EBITDA of ₹12.73 Lakh (EBITDA margin 11.3%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.

As per MCA filings, the company has open charges of ₹77.35 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239TG2005PTC045669
Registration Number 045669
Incorporation Date 18 March 2005
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Index Therapeutics has one previous CIN (Corporate Identification Number): U24239AP2005PTC045669. The current CIN is U24239TG2005PTC045669, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2005PTC045669Current
U24239AP2005PTC045669Previous

Contact details

Index Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    3 – 11 – 102/52 Behind Hanuman Temple Bhavani Nagar Mallapur, Hyderabad, Telangana, India – 500076
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Index Therapeutics Private Limited, buy the company report.

Comprehensive company report
Index Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Index Therapeutics is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Index Therapeutics Private Limited, buy the company report.

Financials of Index Therapeutics Private Limited

FY 2025 filings available

Index Therapeutics Private Limited reported revenue of ₹1.13 Cr (up 11% YoY) for FY 2024.

Revenue · FY 2024
₹1.13 Cr ▲ 11%
Net profit · FY 2024
₹2.09 Lakh margin 1.9%
EBITDA · FY 2024
₹12.73 Lakh margin 11.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 2%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 5%
5 years · compounded
▲ 5%

Revenue rose 11% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹12.73 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.09 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin11.3%
Net Profit Margin1.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Index Therapeutics Private Limited, buy the company report.

Board of directors of Index Therapeutics Private Limited

Index Therapeutics has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Joicy JohnsonDirector10 May 200620 Years 5 MonthsCurrent
Francis Johnson PuthukkaraManaging Director18 Mar 200521 Years 7 MonthsCurrent

Peer comparison

Index Therapeutics Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sam Marino Labs Private Limited₹1.13 Cr (FY 2024)23.0%Lucknow, Uttar Pradesh, India
Kadam Pharma Private Limited₹1.13 Cr (FY 2025)-88.0%Aurangabad, Maharashtra, India
Index Therapeutics Private Limitedthis company₹1.13 Cr (FY 2024)₹2.09 Lakh1.9%11.0%Hyderabad, Telangana, India
Davabikri Solution Private Limited₹1.12 Cr (FY 2025)-29.0%Faridabad, Haryana, India
Ambiens Pharmaceuticals Private Limited₹1.12 Cr (FY 2025)119.0%Csa, Uttar Pradesh, India
GSL Biotech Private Limited₹1.12 Cr (FY 2024)51.0%Pune, Maharashtra, India

To see the full peer comparison of Index Therapeutics Private Limited, buy the company report.

Auditor

Index Therapeutics Private Limited is audited by S N M NANDURY & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
S N M NANDURY & COFY 2019006199S

Shareholding

The shareholding of Index Therapeutics Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Index Therapeutics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹77.35 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.77 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Sep 2024101015493Hdfc Bank Limited₹25.17 LakhOpen
14 Dec 2022100696187Hdfc Bank Limited₹10.54 LakhOpen
17 Dec 2021100540153Hdfc Bank Limited₹5.62 LakhOpen
19 Nov 2020100393391Hdfc Bank Limited₹36.02 LakhOpen

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Index Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Index Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AABCI3485K1ZATelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Index Therapeutics Private Limited, buy the company report.

Recent activity

Index Therapeutics Private Limited has 2 board changes on record since 2005: 2 appointments. The latest: Joicy Johnson was appointed as Director on 10 May 2006.

AGM
Index Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Index Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.17 Lakh with Charge ID 101015493 was registered on 06 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.54 Lakh with Charge ID 100696187 was registered on 14 Dec 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.62 Lakh with Charge ID 100540153 was registered on 17 Dec 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 36.02 Lakh with Charge ID 100393391 was registered on 19 Nov 2020.
Appointed
Joicy Johnson was appointed as Director.
Appointed
Francis Johnson Puthukkara was appointed as Managing Director.
Incorporation
18 Mar 2005
Index Therapeutics Private Limited was registered on 18 Mar 2005 with Roc Hyderabad & aged 21 years 7 months as per MCA records.

Frequently asked questions

Index Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 March 2005 (21+ years old) and is registered under CIN U24239TG2005PTC045669.

Index Therapeutics has 2 current directors:

The latest financial statements of Index Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Index Therapeutics is 36AABCI3485K1ZA, registered in Telangana.

The CIN (Corporate Identification Number) of Index Therapeutics is U24239TG2005PTC045669. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Index Therapeutics was incorporated on 18 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Index Therapeutics by revenue are Sam Marino Labs Private Limited, Kadam Pharma Private Limited, Davabikri Solution Private Limited, Ambiens Pharmaceuticals Private Limited, GSL Biotech Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Joicy Johnson was appointed as Director on 10 May 2006. Francis Johnson Puthukkara was appointed as Managing Director on 18 Mar 2005.

The registered office of Index Therapeutics is at 3 – 11 – 10252 Behind Hanuman Temple Bhavani Nagar Mallapur, Hyderabad, Telangana, India – 500076.

Index Therapeutics operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Index Therapeutics has open charges of ₹77.35 Lakh and no satisfied charges on record as per latest MCA filings.